J Virol. 1992 Jun;66(6):3531-7.

Human immunodeficiency virus type 2 infection and fusion of CD4-negative human cell lines: induction and enhancement by soluble CD4.

Source

Chester Beatty Laboratories, Institute of Cancer Research, London, England.

Abstract

We describe human immunodeficiency type 2 (HIV-2) strains which induce cell-to-cell fusion and infect certain CD4- human cell lines. Soluble CD4 (sCD4) induces or enhances fusion by most HIV-2 strains tested. Soluble CD4-immunoglobulin G chimeras and conjugates of sCD4 and antibody to the third domain of CD4 block HIV-2 fusion of CD4- cells. We conclude that HIV-2 can enter CD4- cells via an alternative cell surface receptor to CD4. While some strains entered efficiently, others retained a dependency on an interaction with sCD4 to initiate changes in the virion envelope required for membrane fusion.

PMID:: 1583722; [PubMed - indexed for MEDLINE]
PMCID:: PMC241134

Free PMC Article

Publication Types, MeSH Terms, Substances

Publication Types

Research Support, Non-U.S. Gov't

MeSH Terms

Substances

LinkOut - more resources

Full Text Sources

Other Literature Sources

Labome Researcher Resource - ExactAntigen/Labome

Medical

Human Herpesvirus-8 - HIV InSite

Supplemental Content

Save items

Related citations in PubMed

CD4 molecules with a diversity of mutations encompassing the CDR3 region efficiently support human immunodeficiency virus type 1 envelope glycoprotein-mediated cell fusion. [J Virol. 1993]
CD4 molecules with a diversity of mutations encompassing the CDR3 region efficiently support human immunodeficiency virus type 1 envelope glycoprotein-mediated cell fusion.
Broder CC, Berger EA. J Virol. 1993 Feb; 67(2):913-26.
Conformational changes induced in the envelope glycoproteins of the human and simian immunodeficiency viruses by soluble receptor binding. [J Virol. 1993]
Conformational changes induced in the envelope glycoproteins of the human and simian immunodeficiency viruses by soluble receptor binding.
Sattentau QJ, Moore JP, Vignaux F, Traincard F, Poignard P. J Virol. 1993 Dec; 67(12):7383-93.
Human immunodeficiency virus type 2 envelope glycoprotein: differential CD4 interactions of soluble gp120 versus the assembled envelope complex. [Virology. 1992]
Human immunodeficiency virus type 2 envelope glycoprotein: differential CD4 interactions of soluble gp120 versus the assembled envelope complex.
Mulligan MJ, Ritter GD Jr, Chaikin MA, Yamshchikov GV, Kumar P, Hahn BH, Sweet RW, Compans RW. Virology. 1992 Mar; 187(1):233-41.
Review The role of CD4 in HIV binding and entry. [Philos Trans R Soc Lond B Biol...]
Review The role of CD4 in HIV binding and entry.
Sattentau QJ, Moore JP. Philos Trans R Soc Lond B Biol Sci. 1993 Oct 29; 342(1299):59-66.
Review The CD4-gp120 interaction and AIDS pathogenesis. [Annu Rev Immunol. 1991]
Review The CD4-gp120 interaction and AIDS pathogenesis.
Capon DJ, Ward RH. Annu Rev Immunol. 1991; 9:649-78.

See reviews... See all...

Cited by 69 PubMed Central articles

Gyrase B inhibitor impairs HIV-1 replication by targeting Hsp90 and the capsid protein. [J Biol Chem. 2010]
Gyrase B inhibitor impairs HIV-1 replication by targeting Hsp90 and the capsid protein.
Vozzolo L, Loh B, Gane PJ, Tribak M, Zhou L, Anderson I, Nyakatura E, Jenner RG, Selwood D, Fassati A. J Biol Chem. 2010 Dec 10; 285(50):39314-28. Epub 2010 Oct 11.
Insulin degrading enzyme induces a conformational change in varicella-zoster virus gE, and enhances virus infectivity and stability. [PLoS One. 2010]
Insulin degrading enzyme induces a conformational change in varicella-zoster virus gE, and enhances virus infectivity and stability.
Li Q, Ali MA, Wang K, Sayre D, Hamel FG, Fischer ER, Bennett RG, Cohen JI. PLoS One. 2010 Jun 25; 5(6):e11327. Epub 2010 Jun 25.
Inhibition of HIV-1 replication by isoxazolidine and isoxazole sulfonamides. [Chem Biol Drug Des. 2010]
Inhibition of HIV-1 replication by isoxazolidine and isoxazole sulfonamides.
Loh B, Vozzolo L, Mok BJ, Lee CC, Fitzmaurice RJ, Caddick S, Fassati A. Chem Biol Drug Des. 2010 May; 75(5):461-74.

See all...

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
References for this PMC Article
Citation referenced in PubMed article. Only valid for PubMed citations that are also in PMC.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Free in PMC
Free full text articles in PMC
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.
Cited in Books
NCBI Bookshelf books that cite the current articles.

Recent activity

Clear Turn Off Turn On

Human immunodeficiency virus type 2 infection and fusion of CD4-negative human c...
Human immunodeficiency virus type 2 infection and fusion of CD4-negative human cell lines: induction and enhancement by soluble CD4.
J Virol. 1992 Jun ;66(6):3531-7.

PubMed
The projected health benefits of maternal group B streptococcal vaccination in t...
The projected health benefits of maternal group B streptococcal vaccination in the era of chemoprophylaxis.
Vaccine. 2005 May 2 ;23(24):3187-95.

PubMed
Cherubism.
Cherubism.
J Otolaryngol. 1992 Apr ;21(2):84-7.

PubMed
Role of Terminalia arjuna in ischaemic mitral regurgitation.
Role of Terminalia arjuna in ischaemic mitral regurgitation.
Int J Cardiol. 2005 Apr 28 ;100(3):507-8.

PubMed
Opioid analgesia and assessment of the sonographic Murphy sign.
Opioid analgesia and assessment of the sonographic Murphy sign.
J Emerg Med. 2005 May ;28(4):409-13.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to: